Breast Cancer
Conditions
Interventions
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: (1) =18 years old; (2) Female; (3) Patients diagnosed with invasive breast cancer; (4) Complete medical records (including clinical diagnosis, sex, age, date of collection, etc.); (5) At least eight 10 microns FFPE sections provided by every patient; (6) The samples containing at least 20% invasive tumor tissue, and DCIS < 40%; (7) The samples with same IHC result among 3 pathologists (The forth pathologist will be asked to measure one more times when the first three pathologists give different results, and only the results which are concordant among three of the four pathologists will be reserved.
Exclusion criteria
Exclusion criteria: (1) Patients diagnosed with special type invasive breast cancer or non-invasive breast cancer; (2) Patients who dont agree to provide samples or whose sample is not incompetent; (3) Incomplete medical records; (4) Pregnant or breast-feeding women; (5) Patients who are considered not suitable in this clinical trial by researchers; (6) The samples whose IHC results are not concordant among three of the four pathologists.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ERBB2(HER2);ESR1;PGR;MKI67 (Ki-67); | — |
Countries
China
Contacts
Public ContactXiao Chen
Shuwen Biotech Co., Ltd.
Outcome results
None listed